Antidote-like effect of SBECD of plant neurotoxin veratridine on neuro-2a cell viability
A research team consisting of scientists located in Spain and Denmark have successfully proven that the formation of inclusion complexes
Category: CD as API
Methyl BCD against malaria?
The researchers of College of Medicine (Pennsylvania) and Iowa University have published on ‘Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol
International Conference on Orphan Drugs and Rare Diseases
The International conference on Orphan Drugs and Rare Diseases will be taking place during August 8-10, 2022 as a hybrid
Cyclo Therapeutics on Phase 3 Clinical Development Program for Trappsol® Cyclo™ in Niemann-Pick Disease Type C
Businesswire published: Cyclo Therapeutics Announces Formation of Global Steering Committee Comprised of Leading Experts to Advise on the Global Phase
Nature News on Covid drugs: overview and new trends
Over the past two years, the ACTIV programme, run by the US National Institutes of Health (NIH), has included more
HPBCD for Treatment of Parkinson Disease
The recent work of Jarazo et al. demonstrates that HP-β-CD ameliorates the dopaminergic neuronal loss phenotype, confirming the therapeutic potential
Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?
The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as
Sugammadex in Colorectal and da Vinci Surgery
Traditionally, reversal of neuromuscular blocking agents following the completion of surgery was achieved with cholinesterase inhibitors. Recently, sugammadex has been
Combined antioxidants and anti-inflammatory therapies fail to attenuate the early and late phases of cyclodextrin-induced cochlear damage and hearing loss
A major side effect of using high doses of HPβCD to treat Niemann Pick type C (NPC1) disease is sensorineural
Poly-β-cyclodextrin Supramolecular Nanoassembly with a pH-Sensitive Switch Removing Lysosomal Cholesterol Crystals for Antiatherosclerosis
Cholesterol crystals (CCs), originally accumulating in the lysosome of cholesterol-laden cells, can aggravate the progression of atherosclerosis. β-cyclodextrin (CD) is